Back to Search Start Over

The association between bone turnover markers and kyphosis in community-dwelling older adults.

Authors :
McDaniels-Davidson CR
Kritz-Silverstein D
Huang MH
Laughlin GA
Johnson S
Haapalahti J
Schneider DL
Barrett-Connor E
Kado DM
Source :
Bone reports [Bone Rep] 2016 Apr 08; Vol. 5, pp. 57-61. Date of Electronic Publication: 2016 Apr 08 (Print Publication: 2016).
Publication Year :
2016

Abstract

Purpose: Hyperkyphosis, accentuated curvature of the thoracic spine, is often attributed to osteoporosis, yet its underlying pathophysiology is not well understood. Bone turnover markers (BTM) reflect the dynamic process of bone formation and resorption. This study examined the association between serum BTM levels and kyphosis in community-dwelling older adults.<br />Methods: Between 2003 and 2006, 760 men and women in the Rancho Bernardo Study age 60 and older had blood drawn and kyphosis measured. Fasting serum was assayed for N-telopeptide (NTX) and procollagen type 1 n-terminal propeptide (P1NP), markers of bone resorption and formation, respectively. Participants requiring two or more 1.7 cm blocks under their head to achieve a neutral supine position were classified as having accentuated kyphosis. Analyses were stratified by sex and use of estrogen therapy (ET). Odds of accentuated kyphosis were calculated for each standard deviation increase in log-transformed BTM.<br />Results: Mean age was 75 years. Overall, 51% of 341 non-ET using women, 41% of 111 ET-using women, and 75% of 308 men had accentuated kyphosis. In adjusted models, higher P1NP and NTX were associated with decreased odds of accentuated kyphosis in non-ET using women (P1NP: OR = 0.78 [95% CI, 0.58-0.92]; NTX: OR = 0.68 [95% CI, 0.54-0.86]), but not in men or ET-using women ( p  > 0.05).<br />Conclusions: The selective association of higher bone turnover with reduced odds of accentuated kyphosis in non-ET using women suggests that elevated BTM were associated with a lower likelihood of hyperkyphosis only in the low estrogen/high BTM environment characteristic of postmenopausal women who are not using ET.<br />Competing Interests: Dr. Sarah Johnson is a Senior Research Scientist at SPD Development Company Limited, the entity that performed the NTX assays.

Details

Language :
English
ISSN :
2352-1872
Volume :
5
Database :
MEDLINE
Journal :
Bone reports
Publication Type :
Academic Journal
Accession number :
27868084
Full Text :
https://doi.org/10.1016/j.bonr.2016.04.001